- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 20-F Annual report (foreign)
- 8.1 Sinovac Biotech LTD. 20-F, List of Subsidiaries
- 12.1 Sinovac Biotech LTD. 20-F, Certification 302, CEO
- 12.2 Sinovac Biotech LTD. 20-F, Certification 302, CFO
- 13.1 Sinovac Biotech LTD. 20-F, Certification 906, CEO
- 13.2 Sinovac Biotech LTD. 20-F, Certification 906, CFO
EXHIBIT 13.1
Certification by the Chief Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the annual report of Sinovac Biotech Ltd. (the “Company”) on Form 20-F for the year ended December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Weidong Yin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| ||
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: April 5, 2007
By: /s/ Weidong Yin
Name: Weidong Yin
Title: Chief Executive Officer